Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Vyriad, Inc.
Silverback Therapeutics